1001165-13-4

Basic information

• Product Name: ethyl ester of 3-[[2-(4-fluorophenoxy)ethyl]amino]-3-oxo-N-[(phenylmethoxy)carbonyl]alanine
• Synonyms: ethyl ester of 3-[[2-(4-fluorophenoxy)ethyl]amino]-3-oxo-N-[(phenylmethoxy)carbonyl]alanine
• CAS NO: 1001165-13-4
• Molecular Weight: 418.422
• Mol File: 1001165-13-4.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: ethyl ester of 3-[[2-(4-fluorophenoxy)ethyl]amino]-3-oxo-N-[(phenylmethoxy)carbonyl]alanine(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl ester of 3-[[2-(4-fluorophenoxy)ethyl]amino]-3-oxo-N-[(phenylmethoxy)carbonyl]alanine(1001165-13-4)
• EPA Substance Registry System: ethyl ester of 3-[[2-(4-fluorophenoxy)ethyl]amino]-3-oxo-N-[(phenylmethoxy)carbonyl]alanine(1001165-13-4)

Safety Data

• Hazardous Substances Data: 1001165-13-4(Hazardous Substances Data)

Upstream product

• 6096-89-5 2-(4-fluorophenoxy)-1-ethylamine 
• 7682-49-7 N^α-(carbobenzyloxy)-α-carbethoxyglycine 

Relevant articles and documents

USE OF AMPK-ACTIVATING IMIDAZOLE DERIVATIVES, PREPARATION PROCESS THEREFOR AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM

The invention relates to the use of imidazole derivatives of the formula (I): in which A, R'1, R'2 and R'3 are as defined in the description, as AMPK activators. The invention also relates to processes for the preparation of the said compounds, to their uses for the preparation of medicaments for the treatment of insulin resistance, diabetes and related pathologies, and also obesity, and to the pharmaceutical compositions comprising them. Certain compounds of the formula (I) are novel and, in this respect, also form part of the invention.